NCT04740645View on ClinicalTrials.gov

NOCDURNA PASS Study Using Registries in Denmark, Germany and Sweden

CompletedOBSERVATIONAL
Enrollment

1,099,545

Participants

Timeline

Start Date

July 13, 2021

Primary Completion Date

November 1, 2023

Study Completion Date

November 1, 2023

Conditions
Adverse Drug Event
Interventions
OTHER

NOCDURNA Cohort

Non intervention

OTHER

LUTS Cohort

Non intervention

Trial Locations (1)

Unknown

German health care register, BIPS (there may be other sites), Bremen

Sponsors
All Listed Sponsors
lead

Ferring Pharmaceuticals

INDUSTRY

NCT04740645 - NOCDURNA PASS Study Using Registries in Denmark, Germany and Sweden | Biotech Hunter | Biotech Hunter